Diplomatic envoys and global health experts representing the 194 member states of the World Health Organization (WHO) concluded an intensive two-week negotiating session in Geneva today, recording substantial breakthroughs on the draft of the world's first legally binding global pandemic accord. The 11th meeting of the Intergovernmental Negotiating Body (INB11) resolved long-standing stalemates over pathogen data sharing, equitable vaccine allocations, and pandemic prevention protocols.
The treaty process, initiated in late 2021 following the catastrophic human and economic fallout of the COVID-19 pandemic, seeks to establish a permanent multilateral architecture to prevent, prepare for, and respond to future global health emergencies. The latest consensus achieved at WHO headquarters in Geneva clears major hurdles ahead of a proposed special session of the World Health Assembly.
Breakthrough on Pathogen Access and Benefit-Sharing
At the core of the Geneva compromise is Article 12, establishing the Pathogen Access and Benefit-Sharing (PABS) system. Under the provisional agreement, sovereign states that rapidly identify and upload genetic sequence data of pathogens with pandemic potential to open-access databases will be guaranteed tangible benefits. Global pharmaceutical manufacturers accessing that genomic data will be legally required to allocate up to 20% of their real-time production of vaccines, diagnostic tests, and therapeutics to the WHO during health emergencies—split evenly between free humanitarian donations and affordable at-cost supplies for developing nations.
Delegations also finalized harmonized text on Article 4 regarding 'One Health' surveillance, strengthening veterinary, environmental, and human pathogen monitoring without imposing burdensome national sovereignty infringements that had stalled earlier deliberations. Provisions on supply chain diversification will mandate regional stockpiles across Africa, Latin America, and Southeast Asia.
“A pandemic agreement is not an abstract diplomatic document; it is a sacred covenant with future generations that the tragic inequities and vaccine nationalism of COVID-19 will never be repeated.”
Securing Equitable Financing and Technology Transfer
Crucial progress was additionally achieved on Article 11, which outlines voluntary technology transfer mechanisms, know-how sharing, and intellectual property flexibility under the WTO TRIPS framework. Negotiators established a multilateral Coordinating Financial Mechanism designed to channel predictable pooled funding into local laboratory capacity, cold-chain infrastructure, and frontline healthcare workforce training across low-income regions.
INB Co-Chairs Precious Matsoso of South Africa and Roland Driece of the Netherlands expressed confidence that member states have demonstrated the political courage necessary to bring the historic pact across the finish line. Informal drafting groups will continue consultations over technical annexes through October, aiming to deliver a finalized treaty text for formal ratification.
Comments (0)
Log in to join the discussion.